Read + Share
Amedeo Smart
Independent Medical Education
Otsubo K, Kishimoto J, Ando M, Kenmotsu H, et al. Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial. Eur Respir J 2022 Mar 31. pii: 13993003.00380-2022.PMID: 35361630
Email
LinkedIn
Facebook
Twitter
Privacy Policy